Optimal Duration of Adjuvant Endocrine Therapy Undecided in ER+ Breast Cancer

Maryann J. Kwa, MD, discusses the optimal duration of endocrine therapy in the treatment of patients with early-stage ER-positive breast cancer.

More From BioPortfolio on "Optimal Duration of Adjuvant Endocrine Therapy Undecided in ER+ Breast Cancer"